Literature DB >> 16025283

Neuronal intranuclear inclusions are ultrastructurally and immunologically distinct from cytoplasmic inclusions of neuronal intermediate filament inclusion disease.

Sabrina Mosaheb1, Julian R Thorpe, Lida Hashemzadeh-Bonehi, Eileen H Bigio, Marla Gearing, Nigel J Cairns.   

Abstract

Abnormal neuronal cytoplasmic inclusions (NCIs) containing aggregates of alpha-internexin and the neurofilament (NF) subunits, NF-H, NF-M, and NF-L, are the signature lesions of neuronal intermediate filament (IF) inclusion disease (NIFID). The disease has a clinically heterogeneous phenotype, including frontotemporal dementia, pyramidal and extrapyramidal signs presenting at a young age. NCIs are variably ubiquitinated and about half of cases also have neuronal intranuclear inclusions (NIIs), which are also ubiquitinated. NIIs have been described in polyglutamine-repeat expansion diseases, where they are strongly ubiquitin immunoreactive. The fine structure of NIIs of NIFID has not previously been described. Therefore, to determine the ultrastructure of NIIs, immunoelectron microscopy was undertaken on NIFID cases and normal aged control brains. Our results indicate that the NIIs of NIFID are strongly ubiquitin immunoreactive. However, unlike NCIs which contain ubiquitin, alpha-internexin and NF epitopes, NIIs contain neither epitopes of alpha-internexin nor NF subunits. Neither NIIs nor NCIs were recognised by antibodies to expanded polyglutamine repeats. The NII of NIFID lacks a limiting membrane and contains straight filaments of 20 nm mean width (range 11-35 nm), while NCIs contain filaments with a mean width of 10 nm (range 5-18 nm; t-test, P<0.001). Biochemistry revealed no differences in neuronal IF protein mobilities between NIFID and normal brain tissue. Therefore, NIIs of NIFID contain filaments morphologically and immunologically distinct from those of NCIs, and both types of inclusion lack expanded polyglutamine tracts of the triplet-repeat expansion diseases. These observations indicate that abnormal protein aggregation follows separate pathways in different neuronal compartments of NIFID.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16025283      PMCID: PMC1388263          DOI: 10.1007/s00401-005-1057-x

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  34 in total

1.  Polyglutamine-containing aggregates in neuronal intranuclear inclusion disease.

Authors:  A P Lieberman; Y Robitaille; J Q Trojanowski; D W Dickson; K H Fischbeck
Journal:  Lancet       Date:  1998-03-21       Impact factor: 79.321

Review 2.  Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases?

Authors:  C A Ross
Journal:  Neuron       Date:  1997-12       Impact factor: 17.173

3.  Are neuronal intranuclear inclusions the common neuropathology of triplet-repeat disorders with polyglutamine-repeat expansions?

Authors:  S W Davies; K Beardsall; M Turmaine; M DiFiglia; N Aronin; G P Bates
Journal:  Lancet       Date:  1998-01-10       Impact factor: 79.321

4.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain.

Authors:  M DiFiglia; E Sapp; K O Chase; S W Davies; G P Bates; J P Vonsattel; N Aronin
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease.

Authors:  N J Cairns; M Grossman; S E Arnold; D J Burn; E Jaros; R H Perry; C Duyckaerts; B Stankoff; B Pillon; K Skullerud; F F Cruz-Sanchez; E H Bigio; I R A Mackenzie; M Gearing; J L Juncos; J D Glass; H Yokoo; Y Nakazato; S Mosaheb; J R Thorpe; K Uryu; V M-Y Lee; J Q Trojanowski
Journal:  Neurology       Date:  2004-10-26       Impact factor: 9.910

7.  A quantitative investigation of neuronal cytoplasmic and intranuclear inclusions in the pontine and inferior olivary nuclei in multiple system atrophy.

Authors:  M Nishie; F Mori; M Yoshimoto; H Takahashi; K Wakabayashi
Journal:  Neuropathol Appl Neurobiol       Date:  2004-10       Impact factor: 8.090

8.  Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies.

Authors:  M G Spillantini; R A Crowther; R Jakes; N J Cairns; P L Lantos; M Goedert
Journal:  Neurosci Lett       Date:  1998-07-31       Impact factor: 3.046

9.  Neurofilament inclusion body disease with early onset frontotemporal dementia and primary lateral sclerosis.

Authors:  I R A Mackenzie; H Feldman
Journal:  Clin Neuropathol       Date:  2004 Jul-Aug       Impact factor: 1.368

10.  Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1.

Authors:  C J Cummings; M A Mancini; B Antalffy; D B DeFranco; H T Orr; H Y Zoghbi
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

View more
  6 in total

1.  Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease.

Authors:  Manuela Neumann; Sigrun Roeber; Hans A Kretzschmar; Rosa Rademakers; Matt Baker; Ian R A Mackenzie
Journal:  Acta Neuropathol       Date:  2009-08-09       Impact factor: 17.088

2.  FUS immunogold labeling TEM analysis of the neuronal cytoplasmic inclusions of neuronal intermediate filament inclusion disease: a frontotemporal lobar degeneration with FUS proteinopathy.

Authors:  Tristan Page; Michael A Gitcho; Sabrina Mosaheb; Deborah Carter; Sumi Chakraverty; Robert H Perry; Eileen H Bigio; Marla Gearing; Isidre Ferrer; Alison M Goate; Nigel J Cairns; Julian R Thorpe
Journal:  J Mol Neurosci       Date:  2011-05-21       Impact factor: 3.444

3.  ALS-associated fused in sarcoma (FUS) mutations disrupt Transportin-mediated nuclear import.

Authors:  Dorothee Dormann; Ramona Rodde; Dieter Edbauer; Eva Bentmann; Ingeborg Fischer; Alexander Hruscha; Manuel E Than; Ian R A Mackenzie; Anja Capell; Bettina Schmid; Manuela Neumann; Christian Haass
Journal:  EMBO J       Date:  2010-07-06       Impact factor: 11.598

Review 4.  Neuronal intranuclear inclusion disease: recognition and update.

Authors:  Xi Lu; Daojun Hong
Journal:  J Neural Transm (Vienna)       Date:  2021-02-18       Impact factor: 3.575

Review 5.  Specialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders.

Authors:  Aidong Yuan; Ralph A Nixon
Journal:  Brain Res Bull       Date:  2016-09-05       Impact factor: 4.077

6.  Fine structural analysis of the neuronal inclusions of frontotemporal lobar degeneration with TDP-43 proteinopathy.

Authors:  Julian R Thorpe; Helen Tang; Joe Atherton; Nigel J Cairns
Journal:  J Neural Transm (Vienna)       Date:  2008-10-31       Impact factor: 3.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.